Turn.io Launches Behaviour Change Chat Platform for Social Impact

SAN FRANCISCO, Oct. 23, 2019 /PRNewswire/ — Against the background of an increased focus on the role of technology to solve some of the world’s biggest challenges, today sees the launch of Turn.io a product that leverages messaging platforms for social impact.

Turn.io is a startup incubated by Praekelt.org, an early partner in the WhatsApp Business API pilot programme. Developed to connect social impact organisations with audiences using chat messaging platforms like WhatsApp and Google’s Android Messages, Turn.io is underpinned by the crucial role of chat as the growing platform of choice for the majority world.

“Every day there are over a billion opportunities to have conversations that can improve lives,” says Turn.io co-founder, Simon de Haan, from San Francisco where he’s currently attending the 2019 Social Capital Markets Conference.

“However, conversations only have value if they have an impact. We believe that having an impactful conversation at a key moment can positively change someone’s life”.

When MomConnect, a digital maternal health programme, was launched in partnership with South Africa’s National Department of Health in 2014, it quickly reached national scale cited as a global measure of what a mobile health programme can achieve. Developed by Praekelt.org, MomConnect launched as an SMS messaging service, but by 2017, the number of users made it difficult to manage and track key behavioural change conversations.

To solve this, Turn.io  was developed to manage conversations with mothers. It changed the way mothers communicate and instantly triggered a necessary and continuous evolution of the technology platform that drives MomConnect.

Since 2018, Turn.io has developed features and functionality to enhance the use of chat for social enterprises such as using Natural Language Processing & Machine Learning to triage the most urgent conversations, ensuring conversations start at the right time with the right people.

“By 2021, we want to support hundreds of social impact organisations working in health, education, finance and agriculture, serving millions of active users.” says Pippa Yeats, Turn.io’s Product Manager.

To build a strong evidence base as an enabler for both engagement and behaviour change, Turn is currently working with organisations that already run scaled messaging programmes, or who have a robust theory of change, including Noora Health, Girl Effect and Nivi amongst others.

Photo: http://ww.healthtechnologynet.com/wp-content/uploads/2019/10/Turn_io.jpg

Contact Turn.io –
impact@turn.io 
turn.io
@turn_io 
LinkedIn
Lieze Langford – +44 (0)779-195-0625

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/turnio-launches-behaviour-change-chat-platform-for-social-impact-300944025.html

SOURCE Turn.io

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

6 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

7 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

7 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago